SCHEMBL18790989

SCHEMBL18790989

CCOC(=O)CN1CCN(c2cncc(-c3ccccc3C)n2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 4/20 0.46
▸ HTR1A P08908 1/20 0.45
▸ HTR2C P28335 1/20 0.45
▸ ITGB2 P05107 1/20 0.41
▸ ICAM1 P05362 1/20 0.41
▸ ITGAL P20701 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ ATM Q13315 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ PIM2 Q9P1W9 2/20 0.39
▸ RAF1 P04049 1/20 0.38
▸ BRAF P15056 1/20 0.38
▸ CDK4 P11802 1/20 0.38
▸ CDK6 Q00534 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18790985 0.88 CYP11B2 (0.48) CYP11B2PIM2RAF1BRAF
SCHEMBL18791038 0.79 CYP11B2 (0.64) CYP11B2HTR1AHTR2CITGB2ICAM1
SCHEMBL4997526 0.76 CYP11B2 (0.51) CYP11B2ALDH1A1MAPTHTTHSD17B10
SCHEMBL18790689 0.76 CYP11B2 (0.44) CYP11B2HTR1AHTR2CITGB2ICAM1
SCHEMBL905356 0.75 TACR1 (0.44) CYP11B2ITGB2ICAM1ITGALALDH1A1
SCHEMBL3436279 0.75 MAPT (0.57) ALDH1A1MAPTATMBACE1KDM4E
SCHEMBL5003463 0.74 CYP11B2 (0.49) CYP11B2ALDH1A1MAPTHTTRAF1
SCHEMBL18790992 0.74 CYP1A2 (0.60) HTR1AHTR2CALDH1A1HSD17B10PIM2
SCHEMBL18790987 0.74 CYP11B2 (0.53) CYP11B2ALDH1A1
SCHEMBL5000713 0.73 LMNA (0.57) ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3381904-B1 NOVEL NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORP (JP) 2021-07-28 — — EP disclosed
US-10717731-B2 Nitrogen-containing aromatic heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2020-07-21 — — US disclosed
WO-2017069226-A1 NOVEL NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND 田辺三菱製薬株式会社 2017-04-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10717731-B2 Nitrogen-containing aromatic heterocyclic compound REN, NR3C2, NR5A1 CYP11B2 8/4885HTR1A 2659/4885HTR2C 3119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback